Bio Medica Lab

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE1BKA01015
  • NSEID: BMLL
  • BSEID:
INR
104.55
-5.5 (-5.0%)
BSENSE

Jun 02

BSE+NSE Vol: 7000

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Balance Sheet Analysis Highlights
stock-summary

Borrowings

YoY Growth in year ended Mar 2025 is 43.09% vs 9.16% in Mar 2024

stock-summary

Other Long Term Liabilities

YoY Growth in year ended Mar 2025 is 133.33% vs 0.00% in Mar 2024

stock-summary

Fixed Assets

YoY Growth in year ended Mar 2025 is -14.55% vs 5.05% in Mar 2024

stock-summary

Investments

No Investments in the last few periods;

stock-summary

Current Assets

YoY Growth in year ended Mar 2025 is 194.69% vs 15.93% in Mar 2024

Compare Balance Sheet Results of Bio Medica Lab
Markets Mojo
Figures in Cr
Standalone - Balance Sheet Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
9.18
21.04
-11.86
-56.37%
Share Warrants & Outstandings
Total Reserve
5.55
160.76
-155.21
-96.55%
Shareholder's Funds
14.73
181.80
-167.07
-91.90%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
6.76
0.00
6.76
0.00%
Secured Loans
6.76
0.00
6.76
0.00%
Unsecured Loans
0.00
0.00
0.00
0.00%
Deferred Tax Assets / Liabilities
-0.22
4.49
-4.71
-104.90%
Other Long Term Liabilities
0.63
0.00
0.63
0.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.00
0.00
0.00
0.00%
Total Non-Current Liabilities
7.17
4.49
2.68
59.69%
Current Liabilities
Trade Payables
4.28
18.68
-14.40
-77.09%
Other Current Liabilities
4.47
22.42
-17.95
-80.06%
Short Term Borrowings
8.25
0.03
8.22
27,400.00%
Short Term Provisions
0.00
5.56
-5.56
-100.00%
Total Current Liabilities
16.99
46.69
-29.70
-63.61%
Total Liabilities
38.90
232.98
-194.08
-83.30%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
11.31
51.22
-39.91
-77.92%
Less: Accumulated Depreciation
3.85
30.57
-26.72
-87.41%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
7.46
20.65
-13.19
-63.87%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
0.00
0.00
0.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.21
0.00
0.21
0.00%
Non Current Investments
0.00
18.76
-18.76
-100.00%
Long Term Loans & Advances
0.00
0.72
-0.72
-100.00%
Other Non Current Assets
0.13
1.40
-1.27
-90.71%
Total Non-Current Assets
7.81
41.53
-33.72
-81.19%
Current Assets Loans & Advances
Current Investments
0.00
110.50
-110.50
-100.00%
Inventories
18.14
17.64
0.50
2.83%
Sundry Debtors
4.10
46.83
-42.73
-91.24%
Cash and Bank
0.01
1.68
-1.67
-99.40%
Other Current Assets
1.28
3.90
-2.62
-67.18%
Short Term Loans and Advances
7.57
10.91
-3.34
-30.61%
Total Current Assets
31.09
191.45
-160.36
-83.76%
Net Current Assets (Including Current Investments)
14.10
144.77
-130.67
-90.26%
Total Current Assets Excluding Current Investments
31.09
80.96
-49.87
-61.60%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
38.90
232.98
-194.08
-83.30%
Contingent Liabilities
0.05
6.65
-6.60
-99.25%
Total Debt
15.01
0.03
14.98
49,933.33%
Book Value per share (adjusted)
16.05
86.41
-70.36
-81.43%
Annual - Borrowings
Borrowings 15.01 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 43.09% vs 9.16% in Mar 2024

Annual - Other Long Term Liabilities
Other Long Term Liabilities 0.63 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 133.33% vs 0.00% in Mar 2024

Annual - Fixed Assets
Fixed Assets 7.46 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -14.55% vs 5.05% in Mar 2024

Annual - Investments
Investments 0.00 Cr
in Mar 2025

Figures in Cr
stock-summary

No Investments in the last few periods;

Annual - Current Assets
Current Assets 31.09 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 194.69% vs 15.93% in Mar 2024